MYTELASE vs NEORAL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. MYTELASE and NEORAL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYTELASE	NEORAL
Rating	70/100	70/100
Pharmacy pays	—	~$52.85 /30
Type	RX	RX
Active ingredient	AMBENONIUM CHLORIDE	CYCLOSPORINE
Manufacturer	Sanofi Aventis US	Novartis
Dosage forms	Tablet	Capsule, Solution
Drug class	—	Calcineurin Inhibitor Immunosuppressant
Boxed warning	None	Boxed warning
Half-life	—	about 8.4 hours (range 5 to 18 hours)
Treats	Myasthenia Gravis	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

mytelase neoral

Rating

70/100

Pharmacy pays

—

~$52.85 /30

Type

Active ingredient

AMBENONIUM CHLORIDE

CYCLOSPORINE

Manufacturer

Sanofi Aventis US

Novartis

Dosage forms

Tablet

Capsule, Solution

Drug class

—

Calcineurin Inhibitor Immunosuppressant

Boxed warning

None

Boxed warning

Half-life

—

about 8.4 hours (range 5 to 18 hours)

Treats

Myasthenia Gravis

Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

Frequently asked questions

Which is better-rated, Mytelase or Neoral?

Mytelase and Neoral are tied at 3.5 out of 5 by our independent rating.

What is the difference between Mytelase and Neoral?

Mytelase contains Ambenonium Chloride, while Neoral contains Cyclosporine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.